Inventor · disambiguated record
Lanna Li
Also filed as: LI LANNA
16 granted patents·10 pending applications·47 citations·filing 1999–2011
90Inventor score
Files withASTRAZENECA AB19ANDERSSON KJELL1ASTRAZENECA AB A SWEDEN CORP1BOEKMAN-WINIWARTER SUSANNE DORIS MARGIT1JOHANSSON LARS ANDERS MIKAEL1
Top patents by PatentIndex Score
26 records- 0176US7521461B2Benzoic acid derivatives as modulators of PPAR alpha and gammaASTRAZENECA AB·Filed 2003·Granted Apr 21, 2009·9 cites·10 claims
- 0272US7355069B2Ortho-substituted benzoic acid derivatives for the treatment of insulin resistanceASTRAZENECA AB·Filed 2003·Granted Apr 8, 2008·6 cites·27 claims
- 0372US7256307B2Substituted phenypropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor α(PPAR)ASTRAZENECA AB·Filed 2002·Granted Aug 14, 2007·8 cites·22 claims
- 0467US7582629B2Derivatives of isothiazol-3(2H)-one 1,1-dioxides as liver X receptor modulatorsASTRAZENECA AB·Filed 2006·Granted Sep 1, 2009·1 cites·26 claims
- 0564US6630509B2Phenalkyloxy-phenyl derivativesASTRAZENECA AB·Filed 2000·Granted Oct 7, 2003·4 cites·12 claims
- 0662US8110566B2Therapeutic agents 713JOHANSSON LARS ANDERS MIKAEL·Filed 2010·Granted Feb 7, 2012·2 cites·23 claims
- 0760US7241923B2Phenylalkyloxy-phenyl derivativesASTRAZENECA AB·Filed 2003·Granted Jul 10, 2007·5 cites·16 claims
- 0855US7488844B2Therapeutic agentsASTRAZENECA AB·Filed 2004·Granted Feb 10, 2009·0 cites·20 claims
- 0955US2010016321A1Derivatives of isothiazol-3(2h)-one 1,1-dioxides as liver x receptor modulatorASTRAZENECA AB·Filed 2009·Application pending·0 cites
- 1054US7169810B2Guanidine and amidine acid derivatives and analogs and methods of using the sameASTRAZENECA AB·Filed 2002·Granted Jan 30, 2007·1 cites·11 claims
- 1154US6630600B13-aryl propionic acid derivatives and analogsASTRAZENECA AB·Filed 1999·Granted Oct 7, 2003·11 cites·47 claims
- 1253US2007244198A1Carboxylic DerivativesLI LANNA·Filed 2007·Application pending·0 cites
- 1352US2006173204A1New 3-aryl propionic acid derivatives and analogsANDERSSON KJELL·Filed 2006·Application pending·0 cites
- 1450US2004229949A1New 3-aryl propionic acid derivatives and analogsFiled 2003·Application pending·0 cites
- 1550US2006258866A1Carboxylic derivatesASTRAZENECA AB A SWEDEN CORP·Filed 2006·Application pending·0 cites
- 1649US2005148656A1Carboxylic derivatesFiled 2004·Application pending·0 cites
- 1747US7723333B2Non-anilinic derivatives of isothiazol-3(2H)-one 1,1-dioxides as liver X receptor modulatorsASTRAZENECA AB·Filed 2006·Granted May 25, 2010·0 cites·26 claims
- 1847US7514471B2Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor α (PPAR)ASTRAZENECA AB·Filed 2002·Granted Apr 7, 2009·0 cites·19 claims
- 1947US7462644B2Therapeutic agentsASTRAZENECA AB·Filed 2003·Granted Dec 9, 2008·0 cites·18 claims
- 2044US2007149614A1Guanidine and amidine acid derivatives and analogs and methods of using the sameASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 2142US7351858B2Ortho-substituted benzoic acid derivatives for the treatment of insulin resistanceASTRAZENECA AB·Filed 2003·Granted Apr 1, 2008·0 cites·7 claims
- 2242US2008255207A15-Thioxo-1,5-Dihydro-2H-Pyrrol-2-One Derivatives As Liver X Receptor ModulatorsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 2339US7960380B2Non-anilinic derivatives of isothiazol-3(2H)-one 1,1-dioxides as liver X receptor modulatorsASTRAZENECA AB·Filed 2010·Granted Jun 14, 2011·0 cites·17 claims
- 2439US2009029945A2Non-Anilinic Derivatives of Isothiazol-3(2H)-Thione 1,1-Dioxides As Liver X Receptor ModulatorsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 2539US2008319017A2Non-Anilinic Derivatives of Isothiazol-3(2H)-Thione 1,1-Dioxides As Liver X Receptor ModulatorsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 2622US8546375B2(3-(4-(aminomethyl)phenoxy or phenylthio)azetidin-1-yl)(5-phenyl-1,3,4-oxadiazol-2-yl)methanone compoundsBOEKMAN-WINIWARTER SUSANNE DORIS MARGIT·Filed 2011·Granted Oct 1, 2013·0 cites·12 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →